Cleveland BioLabs (CBLI) Announces Quarterly Earnings Results
Cleveland BioLabs (NASDAQ:CBLI) issued its quarterly earnings data on Thursday. The company reported ($0.09) earnings per share (EPS) for the quarter, American Banking News reports.
Shares of Cleveland BioLabs (NASDAQ:CBLI) traded down 4.95% on Thursday, hitting $0.3802. 167,688 shares of the company’s stock traded hands. Cleveland BioLabs has a 52-week low of $0.40 and a 52-week high of $1.84. The stock’s 50-day moving average is $0.48 and its 200-day moving average is $0.61. The company’s market cap is $19.4 million.
Cleveland BioLabs, Inc (NASDAQ:CBLI), incorporated on June 5 2003, is a biotechnology company focused on developing biodefense, tissue protection and cancer treatment drugs based on the concept of modulation of cell death for therapeutic benefit.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.